Part 1/5:
Halo's Transformative Drug Delivery Platform
Halo, a biotech company based in San Diego, has developed a revolutionary drug delivery platform that is transforming the way patients receive cancer and autoimmune disease treatments. Their technology enables the conversion of intravenous therapies, which typically require hour-long infusions, into simple, 3-to-5-minute subcutaneous injections that can be administered in a doctor's office or even at home.